Mr Anthony James Culverwell
Mr Anthony James Culverwell was appointed in a total of 10 companies and resigned from 6 of these appointments.
Roles
Director • Designated LLP Member
Country Of Residence
England
Nationality
British
Date of Birth
August 1956
Occupations
Company Director • Pharmaceutical Exective • Life Science Consult • Healthcare Corporate Consultan • Life Science Consultant • Consultant • Unreported
Active
1
Resigned
6
Dissolved
2
Other
1
Total
10
Companies
| Company | Timeline | Status | |
| Amryt Pharma Holdings Limited Director • Company Director | 19 Apr 2016←3 Years→24 Sep 2019 | Active | |
| Pam Wellness Limited Director • Company Director | 20 Jan 2014←4 Years→10 Jan 2019 | Active | |
| Hox Therapeutics Limited Director • Director | 20 Sep 2013←11 Years→Current | Active | |
Sabrepharm Limited Director • Pharmaceutical Exective | 3 Jul 2007←7 Years→13 Jan 2015 | Dissolved | |
| Safeguard Biosystems Holdings Limited Director • Company Director | 14 Dec 2006←18 Years→Current | In Administration | |
| Cell Analysis Limited Director • Life Science Consult | 23 Nov 2006←8 Years→27 Oct 2015 | Liquidation | |
| 04836342 Limited Director • Healthcare Corporate Consultan | 25 Aug 2006←9 Years→27 Oct 2015 | Dissolved | |
| Blood Analysis Limited Director • Life Science Consultant | 1 Jun 2006←9 Years→27 Oct 2015 | Dissolved | |
| Expedeon Limited Director • Consultant | 30 Mar 2006←3 Years→1 Aug 2009 | Active | |
Sudbrook Associates LLP Designated LLP Member • Unreported | 25 May 2005←9 Years→27 May 2014 | Dissolved | |
Mutual People
- Nigel John Guy BarnesSudbrook Associates LLP and Sabrepharm Limited are mutual companies.
- Mr John Frank RatcliffeBlood Analysis Limited and Cell Analysis Limited are mutual companies.
- Mr Ian AspinallAmryt Pharma Holdings Limited is a mutual company.
- Dr Heikki LanckrietExpedeon Limited is a mutual company.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
